Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Safety needles and safety syringes, as there is protective mechanism for the needle in safety needles rather than syringe. The needles are called safety needles as they have features such as easy to use, and safety anti-needlestick mechanism due to which healthcare professionals and patients are protected from needlestick injuries in hospitals. Safety needles are used for various purposes such as delivery of drugs to the patients and also used in collection of blood from individuals.

Figure 1. U.S. Safety Needles Market Value (US$ Mn), 2016-2027

U.S. Safety Needles  | Coherent Market Insights

The U.S. safety needles market size is estimated to be valued at US$ 2,447.3 million in 2020 and is expected to exhibit a CAGR of 4.8% over the forecast period (2020-2027).

The U.S. safety needles market growth is primarily driven by the increasing incidence of chronic diseases such as cancer, diabetes, and others in the U.S. According to the American Cancer Society 2020 report, estimated 1.8 million new cancer cases were diagnosed and 606,520 cancer deaths were reported in the U.S. in 2020.

Moreover, various strategies adopted by market players include new product launches, acquisitions, and agreements, in order to retain their market position, and this is expected to drive the market growth over the forecast period. For instance, in February 2018, B. Braun Medical Inc, a medical device company focusing on manufacturing of medical devices such as syringes, safety needles and others, introduced its Surecan Safety II Port Access Needles with the safety mechanism, which is designed to reduce the risk of accidental needlestick injuries by shielding the needle tips.

request-sample

U.S. Safety Needles Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$  2,447.3 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 4.8 % 2027 Value Projection: US$  3,408.0 Mn
Geographies covered:
  • North America: U.S.
Segments covered:
  • By Product Type: Fine Aspirating Needle, Biopsy Needle, Hypodermic Needle, Pen Needle, Suture Needle, IV Catheter Needle, Huber Needle, Blood Collection Needle, Spinal Anaesthesia and Epidural Needle, Prefilled Syringe Needle, A.V. Fistula Needle, Cannula Needle, Retractable Syringes.
  • By Application: Sample Collection, Drug Delivery.
  • By End User: Hospitals, Physician Offices, Nursing Home, Dental Laboratories, Diagnostic Centers, Ambulatory Surgical Centers, Homecare Settings, Others.
Companies covered:

Medtronic Plc., Becton, Dickinson and Company, Boston Scientific Corporation, Smith Medical, Abbott Laboratories, Argon Medical Devices, Inc., Novo Nordisk A/S, Terumo Corporation, Eli Lilly and Company, Nipro Corporation, B.Braun Melsungen AG, Revolutions Medical Corporation, Retractable Technologies, Inc, SOL-MILLENNUM, UltiMed, Inc., Axel Bio Corporation, Inc., Cardinal Health, Inc., Vygon S.A., and Gerresheimer AG

Growth Drivers:
  • Increasing prevalence of gynaecologic cancer and spine disorders
  • U.S. government initiatives for blood collection
  • Favourable reimbursement for pen needles by U.S. government
Restraints & Challenges:
  • Increasing development and awareness of needle-free injection technology
  • High incidence of trypanophobia (fear of needles)
  • Safety needles product recall due to low quality and loss of function of the products

U.S. Safety Needles Market- Impact of Coronavirus (Covid-19) Pandemic

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in more than 110 million infected individuals worldwide as of February 19th, 2021.

Safety needles are designed for delivering drugs and collecting fluids from the body with safety features to avoid needlestick injuries. There are various types of safety needles such as fine aspirating needles, biopsy needles, hypodermic needles, pen needles, suture needles, IV catheter needles, Huber needles, blood collection needles, spinal anesthesia and epidural needles, prefilled needles, A.V. fistula needles, and cannula needles.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. In the U.S., according to the latest update by Economic Times, a business daily newspaper and journal, stated that there has been a huge plunge in consumer spending as people stayed at home and avoided shopping, traveling, or gathering in crowds and caused the economy to sink at an estimated annual rate of 32% in the April-June 2020 quarter.

Players operating in the U.S. safety needles market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials for manufacturing safety needles due to irregularities in transportation facility

Figure 2. U.S. Safety Needles Market Share (%), by Product Type, 2020

U.S. Safety Needles  | Coherent Market Insights

The increasing product launches of safety needles in the U.S. used for sample collection is expected to drive growth of the sample collection segment in the forecast period. For instance, in 2016, Nipro Medical Corporation, manufacturer of Renal, Medical-Surgical and Interventional Radiology products, launched SafeTouch Safety Needle, in the U.S. The device has features such as easy to use, and safety anti-needlestick mechanism

Major players operating in the U.S. safety needles market are Medtronic Plc., Becton, Dickinson and Company, Boston Scientific Corporation, Smith Medical, Abbott Laboratories, Argon Medical Devices, Inc., Novo Nordisk A/S, Terumo Corporation, Eli Lilly and Company, Nipro Corporation, B.Braun Melsungen AG, Revolutions Medical Corporation, Retractable Technologies, Inc, SOL-MILLENNUM, UltiMed, Inc., Axel Bio Corporation, Inc., Cardinal Health, Inc., Vygon S.A. and Gerresheimer AG

U.S. Safety Needles Market- Restraints

Increasing development and awareness of needle-free injection technology is expected to hinder growth of the U.S safety needles market. For instance, in December 2019, Nephron Pharmaceuticals Corporation, company focusing on manufacturing of pharmaceutical products and medical devices, partnered with National Medical Products Inc., a developer of J-Tip Needle Free Injector, to provide patients quality care through virtually pain-free anaesthetic.

Moreover, high incidence of trypanophobia (fear of needles) is also expected to limit the growth of the market. For instance, according to the study, ‘The fear of needles: A systematic review and meta-analysis,’ published in the Journal of Advanced Nursing in January 2019, the prevalence of needle fear ranged from 20-50% in adolescents and 20-30% in young adults in U.S.

Safety needles are designed for delivering drugs and collecting fluids from the body with safety features to avoid needle stick injuries. There are various types of safety needles such as fine aspirating needles, biopsy needles, hypodermic needles, pen needles, suture needles, IV catheter needles, Huber needles, blood collection needles, spinal anesthesia and epidural needles, prefilled needles, A.V. fistula needles, and cannula needles.

Market Dynamics

Key companies are focusing on inorganic strategies such as merger and acquisitions, is expected to drive the U.S. safety needles market. For instance, in July 2017, Cardinal Health, Inc, American multinational health care services company, acquired Patient Recovery Business from Medtronic for US$ 6.1 billion. Patient Recovery Business manufactures 23 medical product categories and sells into multiple healthcare channels. The acquisition increased the medical segment's portfolio of self-manufactured products for Cardinal Health.

Moreover, key companies are focusing on investment in expanding their medical devices product portfolio to strengthen their positioning in the market. For instance, in 2019, Nipro Corporation, a medical equipment manufacturing company, announced plans to invest US$ 21 million in JMI Syringes & Medical Devices Ltd., a medical devices manufacturing company, in order to expand its disposable medical devices such as syringes and needles portfolio mainly in North America and Asia Pacific

Key players are focusing on product launches and product approvals to strengthen their presence in the U.S. safety needles market. For instance, in May 2016, Retractable Technologies Inc, a company designs, develops, manufactures, and markets safety needle devices for the healthcare industry, announced the launch of Easy point needles. The safety Easy point needles are developed through automated retraction technology and can be used with luer lock technology, and started marketing and selling of the product mainly in the U.S.

Furthermore, in May 2017, Gerresheimer AG, a medical device company, announced the launch of Gx InnoSafe. The Gx InnoSafe is a syringe with an integrated and passive safety system that prevents unintentional needle stick injuries and also eliminates the possibility of accidental reuse.

Key features of the study:

  • This report provides in-depth analysis of the U.S. safety needles market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020–2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the U.S. safety needles market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The U.S. safety needles market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the U.S. safety needles market
  • Key players operating in the U.S. safety needles market include Medtronic Plc., Becton, Dickinson and Company, Boston Scientific Corporation, Smith Medical, Abbott Laboratories, Argon Medical Devices, Inc., Novo Nordisk A/S, Terumo Corporation, Eli Lilly and Company, Nipro Corporation, B.Braun Melsungen AG, Revolutions Medical Corporation, Retractable Technologies, Inc., SOL-MILLENNUM, UltiMed, Inc., Axel Bio Corporation, Inc., Cardinal Health, Inc., Vygon S.A. and Gerresheimer AG

Detailed Segmentation:

  • U.S. Safety Needles Market, By Product Type :
    • Fine Aspirating Needle
    • Biopsy Needle
    • Hypodermic Needle
    • Pen Needle
    • Suture Needle
    • IV Catheter Needle
    • Huber Needle
    • Blood Collection Needle
    • Spinal Anesthesia and Epidural Needle
    • Prefilled Syringe Needle
    • A.V. Fistula Needle
    • Cannula Needle
    • Retractable Syringes
  • U.S. Safety Needles Market, By Application :
    • Sample Collection
    • Drug Delivery
  • U.S. Safety Needles Market, By End User :
    • Hospitals
    • Physician Offices
    • Nursing Home
    • Dental Laboratories
    • Diagnostic Centers
    • Ambulatory Surgical Centers
    • Homecare Settings
    • Others
  • Company Profiles
    • Medtronic Plc.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • Smith Medical
    • Abbott Laboratories
    • Argon Medical Devices, Inc.
    • Novo Nordisk A/S
    • Terumo Corporation
    • Eli Lilly and Company
    • Nipro Corporation
    • B.Braun Melsungen AG
    • Revolutions Medical Corporation
    • Retractable Technologies, Inc.
    • SOL-MILLENNUM
    • UltiMed, Inc.
    • Axel Bio Corporation, Inc.
    • Cardinal Health, Inc.
    • Vygon S.A.
    • Gerresheimer AG

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Key Developments
    • Product Launch/ Approvals
    • Key Developments
    • Mergers and Acquisition
    • Regulatory Scenario
    • PEST Analysis
    • Porter’s Analysis
    • Technology Landscape
    • Prevalence of Needle Stick Injuries Worldwide        
  4. S. Safety Needles Market, Impact of COVID-19 Pandemic
    • Economic Impact
    • COVID-19 Epidemiology
    • Government Initiatives
  5. S. Safety Needles Market, By Product Type, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
        • Introduction
        • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
        • Segment Trends
          • Fine Aspirating Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Biopsy Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Hypodermic Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Pen Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Suture Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • IV Catheter Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Huber Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Blood Collection Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Spinal Anesthesia and Epidural Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Prefilled Syringe Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • V. Fistula Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Cannula Needle
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn
          • Retractable Syringes
            • Introduction
            • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
  6. S. Safety Needles Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017– 2027
      • Segment Trends
        • Sample Collection
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
        • Drug Delivery
          • Introduction
          • Market size and forecast, and Y-o-Y Growth, 2020-2027, (US$ Mn)
  7. S. Safety Needles Market, By End User, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017– 2027
      • Segment Trends
        • Hospitals
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Physician Offices
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Nursing Home
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Dental Laboratories
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Diagnostic Centers
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Ambulatory Surgical Centers
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Homecare Settings
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  8. Competitive Landscape
    • Company Profiles
      • Medtronic Plc.*
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Smith Medical
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott Laboratories
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Argon Medical Devices, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novo Nordisk A/S
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Eli Lilly and Company
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nipro Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • B.Braun Melsungen AG
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Revolutions Medical Corporation
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Retractable Technologies, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SOL-MILLENNUM
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • UltiMed, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Axel Bio Corporation, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cardinal Health, Inc.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Vygon S.A.
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Gerresheimer AG
        • Company Overview
        • Clinical Trial Phase Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 10 market data tables and 31 figures on ‘U.S. Safety Needles Market– Regional forecast to 2027’.

Frequently Asked Questions

The U.S. safety needles market size is estimated to be valued at US$ 2,447.3 million in 2020 and is expected to exhibit a CAGR of 4.8 % during the forecast period.
Increasing prevalence of gynaecologic cancer and spine disorders, government initiatives for blood collection and favourable reimbursement for pen needles are expected to drive the market.
Blood Collection Needles is estimated to hold major market share in 2020, as increase in blood donations and need for blood components due to increasing patient population.
Drug Delivery segment is estimated to hold major market share in 2020, owing to the increasing launches of safety needle used for drug delivery.
Hospital segment is estimated to hold major market share in 2020, owing to the increasing number of patient population suffering from traumatic injuries and rising hospital visit of patients suffering from chronic conditions to undergo surgeries.
Increasing development and awareness of needle-free injection technology, high incidence of trypanophobia (fear of needles) and safety needles product recall due to low quality and loss of function of the products are the major restraints of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner